Eton Pharmaceuticals, Inc. (ETON)
CIK 1710340 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eton Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 31, 2026 | 4/A | 0001437749-26-029308 |
| Aug 28, 2026 | 4 | 0001437749-26-029196 |
| Aug 28, 2026 | 144 | 0001974078-26-000335 |
| Aug 24, 2026 | 144 | 0001974078-26-000328 |
| Aug 24, 2026 | 4 | 0001437749-26-028846 |
| Aug 20, 2026 | 144/A | 0001974078-26-000322 |
| Aug 20, 2026 | 4 | 0001437749-26-028651 |
| Aug 19, 2026 | 144 | 0001974078-26-000315 |
| Aug 13, 2026 | 10-Q | 0001437749-26-027684 |
| Aug 13, 2026 | 8-K | 0001437749-26-027672 |
| Aug 12, 2026 | 3 | 0001437749-26-027363 |
| Aug 5, 2026 | 8-K | 0001437749-26-025781 |
| Aug 4, 2026 | 4 | 0001437749-26-025712 |
| Aug 4, 2026 | 4 | 0001437749-26-025715 |
| Aug 4, 2026 | 4 | 0001437749-26-025725 |
| Aug 4, 2026 | 4 | 0001437749-26-025709 |
| Aug 4, 2026 | 8-K | 0001437749-26-025506 |
| Aug 4, 2026 | 4 | 0001437749-26-025696 |
| Aug 4, 2026 | 4 | 0001437749-26-025700 |
| Aug 4, 2026 | 4 | 0001437749-26-025694 |
| Aug 4, 2026 | 4 | 0001437749-26-025706 |
| Jul 29, 2026 | 8-K | 0001437749-26-024746 |
| Jul 28, 2026 | SCHEDULE 13G/A | 0002012383-26-002487 |
| Jul 17, 2026 | 4/A | 0001493152-26-033818 |
| Jul 16, 2026 | 4 | 0001493152-26-033577 |